Investments in Innovation November 2023


Pharmathen announced today the acquisition of CBL Patras, a vertically integrated, high-tech peptide manufacturing company approved by the US Food and Drug Administration (FDA). The acquisition of CBL confirms Pharmathen's commitment to innovation and its dedication to long-term growth, further strengthening its position in the global therapeutic peptides market, which is currently valued at €38 billion and is expected to reach €100 billion by 2033.


Danish Teracloud is creating a research centre in Athens. Teracloud was founded in 2015 and employs 400 people worldwide. It has a presence in Malmö, Sweden; Stuttgart, Germany; Yerevan, Armenia; Perth, Australia; and Boston, USA, developing complex technology applications that enable businesses to digitise their processes and become more competitive.

Join Innovative Greeks And help to scale up Greece’s innovation ecosystem for growth, jobs, and prosperity.